BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33377079)

  • 1. An Orthotopic Implantation Mouse Model of Hepatocellular Carcinoma with Underlying Liver Steatosis.
    Kasashima H; Duran A; Cid-Diaz T; Kudo Y; Diaz-Meco MT; Moscat J
    STAR Protoc; 2020 Dec; 1(3):100185. PubMed ID: 33377079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
    Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
    Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models.
    Rao Q; You A; Guo Z; Zuo B; Gao X; Zhang T; Du Z; Wu C; Yin H
    PLoS One; 2016; 11(1):e0148263. PubMed ID: 26824903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.
    Liebig M; Hassanzada A; Kämmerling M; Genz B; Vollmar B; Abshagen K
    Exp Biol Med (Maywood); 2018 Jan; 243(1):1-12. PubMed ID: 29065724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ischaemic preconditioning on recurrence of hepatocellular carcinoma in an experimental model of liver steatosis.
    Orci LA; Lacotte S; Oldani G; Slits F; De Vito C; Crowe LA; Rubbia-Brandt L; Vallée JP; Morel P; Toso C
    Br J Surg; 2016 Mar; 103(4):417-26. PubMed ID: 26891212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis.
    Reiberger T; Chen Y; Ramjiawan RR; Hato T; Fan C; Samuel R; Roberge S; Huang P; Lauwers GY; Zhu AX; Bardeesy N; Jain RK; Duda DG
    Nat Protoc; 2015 Aug; 10(8):1264-74. PubMed ID: 26203823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma.
    Rappa F; Greco A; Podrini C; Cappello F; Foti M; Bourgoin L; Peyrou M; Marino A; Scibetta N; Williams R; Mazzoccoli G; Federici M; Pazienza V; Vinciguerra M
    PLoS One; 2013; 8(1):e54458. PubMed ID: 23372727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
    Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y
    J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protocol for generation of humanized HCC mouse model and cancer-driver mutations using CRISPR-Cas9.
    Zhu Y; Tahara SM; Tsukamoto H; Machida K
    STAR Protoc; 2023 Dec; 4(4):102389. PubMed ID: 38103196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthotopic Model of Hepatocellular Carcinoma in Mice.
    Lambertucci F; Li S; Motiño O; Montégut L; Nogueira-Recalde U; Chen H; Anagnostopoulos G; Maiuri MC; Kroemer G; Martins I
    Methods Mol Biol; 2024; 2769():1-13. PubMed ID: 38315385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo analysis of FBXO45-mediated fibrosis and liver tumorigenesis in a chemically induced mouse model of hepatocellular carcinoma.
    Zhang J; Lin XT; Fang L; Xie CM
    STAR Protoc; 2023 Mar; 4(1):102124. PubMed ID: 36853700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
    Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
    Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in a mouse model fed a choline-deficient, L-amino acid-defined, high-fat diet.
    Ikawa-Yoshida A; Matsuo S; Kato A; Ohmori Y; Higashida A; Kaneko E; Matsumoto M
    Int J Exp Pathol; 2017 Aug; 98(4):221-233. PubMed ID: 28895242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.
    Avella DM; Li G; Schell TD; Liu D; Zhang SS; Lou X; Berg A; Kimchi ET; Tagaram HR; Yang Q; Shereef S; Garcia LS; Kester M; Isom HC; Rountree CB; Staveley-O'Carroll KF
    Hepatology; 2012 Jan; 55(1):141-52. PubMed ID: 21898502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma.
    Thompson KJ; Austin RG; Nazari SS; Gersin KS; Iannitti DA; McKillop IH
    Liver Int; 2018 Jun; 38(6):1074-1083. PubMed ID: 29171144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hyperglycemia on hepatocellular carcinoma development in diabetes.
    Niwa Y; Ishikawa K; Ishigami M; Honda T; Achiwa K; Izumoto T; Maekawa R; Hosokawa K; Iida A; Seino Y; Hamada Y; Goto H; Oiso Y; Arima H; Tsunekawa S
    Biochem Biophys Res Commun; 2015 Jul; 463(3):344-50. PubMed ID: 26022129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from mouse models of high-fat diet-induced NAFLD.
    Nakamura A; Terauchi Y
    Int J Mol Sci; 2013 Oct; 14(11):21240-57. PubMed ID: 24284392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a dual-color fluorescence tracing orthotopic transplantation model of hepatocellular carcinoma.
    Chen Q; Wang X; Wu H; Wang H; Zhu M; Wang R; Wu Y; Zhang L; Meng Q; Song R; Zhuang Z; Huang Q
    Mol Med Rep; 2016 Jan; 13(1):762-8. PubMed ID: 26647736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: a clinical and pathological study.
    Alexander J; Torbenson M; Wu TT; Yeh MM
    J Gastroenterol Hepatol; 2013 May; 28(5):848-54. PubMed ID: 23302015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.